466 related articles for article (PubMed ID: 30337929)
21. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
[TBL] [Abstract][Full Text] [Related]
22. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
23. Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans.
Figueiredo S; Charmeteau B; Surenaud M; Salmon D; Launay O; Guillet JG; Hosmalin A; Gahery H
Vaccine; 2014 Jan; 32(4):492-501. PubMed ID: 24291199
[TBL] [Abstract][Full Text] [Related]
24. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
Wang Y; Aïssi-Rothe L; Virion JM; De Carvalho Bittencourt M; Ulas N; Audonnet S; Salmon A; Clement L; Venard V; Jeulin H; Stoltz JF; Decot V; Bensoussan D
Cytotherapy; 2014 Jan; 16(1):122-34. PubMed ID: 24094498
[TBL] [Abstract][Full Text] [Related]
25. Immune escape by Epstein-Barr virus associated malignancies.
Münz C; Moormann A
Semin Cancer Biol; 2008 Dec; 18(6):381-7. PubMed ID: 18996483
[TBL] [Abstract][Full Text] [Related]
26. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
27. Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors.
Eom HS; Choi BK; Lee Y; Lee H; Yun T; Kim YH; Lee JJ; Kwon BS
J Immunother; 2016 Apr; 39(3):140-8. PubMed ID: 26938947
[TBL] [Abstract][Full Text] [Related]
28. Cross-reactivity influences changes in human influenza A virus and Epstein Barr virus specific CD8 memory T cell receptor alpha and beta repertoires between young and old.
Clark F; Gil A; Thapa I; Aslan N; Ghersi D; Selin LK
Front Immunol; 2022; 13():1011935. PubMed ID: 36923729
[TBL] [Abstract][Full Text] [Related]
29. Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection.
van Baarle D; Kostense S; Hovenkamp E; Ogg G; Nanlohy N; Callan MF; Dukers NH; McMichael AJ; van Oers MH; Miedema F
AIDS; 2002 Oct; 16(15):2001-11. PubMed ID: 12370498
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
31. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
32. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
Silins SL; Cross SM; Elliott SL; Pye SJ; Burrows JM; Moss DJ; Misko IS
Int Immunol; 1997 Nov; 9(11):1745-55. PubMed ID: 9418135
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
Vogl BA; Fagin U; Nerbas L; Schlenke P; Lamprecht P; Jabs WJ
J Med Virol; 2012 Jan; 84(1):119-31. PubMed ID: 22095540
[TBL] [Abstract][Full Text] [Related]
34. HIV infection confers distinct mechanisms in severe drug eruption: Endogenous virus activation with aberrant Th2/Th1 and CD8
Tang JT; Li YY; Zhang Y; Liu J; Guan W; Wang RR; He LP; Zhang JB; Kuang YQ
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1005-1013. PubMed ID: 31991490
[TBL] [Abstract][Full Text] [Related]
35. Loss of T cell receptor Vbeta repertoires in HIV type 1-infected SCID-hu mice.
Boldt-Houle DM; Jamieson BD; Aldrovandi GM; Rinaldo CR; Ehrlich GD; Zack JA
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):125-34. PubMed ID: 9007198
[TBL] [Abstract][Full Text] [Related]
36. A skewed distribution and increased PD-1+Vβ+CD4+/CD8+ T cells in patients with acute myeloid leukemia.
Huang J; Tan J; Chen Y; Huang S; Xu L; Zhang Y; Lu Y; Yu Z; Chen S; Li Y
J Leukoc Biol; 2019 Sep; 106(3):725-732. PubMed ID: 31136687
[TBL] [Abstract][Full Text] [Related]
37. CD4+ T cell responses in the immune control against latent infection by Epstein-Barr virus.
Paludan C; Münz C
Curr Mol Med; 2003 Jun; 3(4):341-7. PubMed ID: 12776989
[TBL] [Abstract][Full Text] [Related]
38. Exhausted cytotoxic control of Epstein-Barr virus in human lupus.
Larsen M; Sauce D; Deback C; Arnaud L; Mathian A; Miyara M; Boutolleau D; Parizot C; Dorgham K; Papagno L; Appay V; Amoura Z; Gorochov G
PLoS Pathog; 2011 Oct; 7(10):e1002328. PubMed ID: 22028659
[TBL] [Abstract][Full Text] [Related]
39. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients.
Petrova M; Muhtarova M; Nikolova M; Magaev S; Taskov H; Nikolovska D; Krastev Z
World J Gastroenterol; 2006 Sep; 12(35):5711-6. PubMed ID: 17007027
[TBL] [Abstract][Full Text] [Related]
40. CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption.
González-Serna A; Abad-Fernández M; Soriano-Sarabia N; Leal M; Vallejo A
J Clin Virol; 2013 Dec; 58(4):703-9. PubMed ID: 24210957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
